Inflammatory bowel disease (IBD) is a chronic disease associated with recurrent
inflammation of the gastrointestinal tract. Recent studies indicate that diet and gut
microbiota have an important influence on the development of the disease, its
course, and treatment effectiveness. This review summarizes knowledge about diet
function in a comprehensive review of current literature concerning the relationship
between nutrition, gut microbiota composition, intestinal barrier integrity, and
inflammatory activity in patients with IBD. The analyzed studies showed that
disturbances in the composition of gut microbiota, known as dysbiosis, are one of
the main factors involved in IBD development. Dysbiosis is characterized by lower
microbial diversity, a reduced number of beneficial bacteria producing short-chain
fatty acids (SCFAs), and an increased number of microorganisms that may promote
inflammation. Special attention has been given to butyrate-producing bacteria
because butyrate helps maintain the integrity of the intestinal barrier and supports
proper immune system function. The review also describes the effects of
pharmacological treatment, including biologic therapies and aminosalicylates, on
reducing inflammation and restoring microbial balance. We have highlighted the
diet as one of the most important nutritional principles for patients with
inflammatory bowel disease (IBD). A diet rich in fruits, fiber, omega-3 fatty acids,
legumes, vegetables, and fermented foods supports the growth of beneficial gut
bacteria and supports the functioning of the intestinal barrier. However, Western
diets and the consumption of processed foods can exacerbate dysbiosis, increase
intestinal permeability, and promote inflammation.
Keywords: Inflammatory bowel disease, Crohn’s disease, Microbiota, Ulcerative
colitis, Mediterranean diet
